Molecular Therapy — Methods & Clinical Development · 2024 · 11 citations · 52 references
Life SciencesGeneticsMolecular BiologyDna RepairGene TherapyGenome EditingCrispr-based EngineeringCrispr-cas SystemsStem Cell Gene TherapyTherapeutic Genome EditingClinical Translation Of Genome EditingCrispr-cas9 Genome EditingDna-pkcsDna-pkcs FunctionHematopoietic Stem Cell EditingHomology-directed Repair PathwayHyper Igm SyndromesHyper-igm Syndrome
Targeted gene editing to restore CD40L expression via homology-directed repair (HDR) in CD34 + hematopoietic stem and progenitor cells (HSPCs) represents a potential long-term therapy for X-linked hyper IgM syndrome. However, clinical translation of HSPC editing is limited by inefficient long-term engraftment of HDR-edited HSPCs. Here, we ameliorate this issue by employing a small-molecule inhibitor of DNA-PKcs, AZD7648, to bias DNA repair mechanisms to facilitate HDR upon CRISPR SpCas9-based gene editing. Using AZD7648 treatment and a clinically relevant HSPC source, mobilized peripheral blood CD34 + cells, we achieve ∼60% HDR efficiency at the CD40LG locus and enhanced engraftment of HDR-edited HSPCs in primary and secondary xenotransplants. Specifically, we observed a 1.6-fold increase of HDR-edited long-term HSPCs in primary transplant recipients without disturbing chimerism levels or differentiation capacity. As CD40L is primarily expressed in T cells, we demonstrate T cell differentiation from HDR-edited HSPCs in vivo and in artificial thymic organoid cultures, and endogenously regulated CD40L expression following activation of in-vivo -derived CD4 + T cells. Our combined findings demonstrate HDR editing at the CD40LG locus at potentially clinically beneficial levels. More broadly, these data support using DNA-PKcs inhibition with AZD7648 as a simple and efficacious addition to HSPC editing platforms.
52
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone, Peyton B. Randolph, Jessie R. Davis et al. · Nature · 2019 · 4.7K citations · Full text
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Anthony E. Boitano, Jian Wang, Russell D. Romeo et al. · Science · 2010 · 1K citations · Full text
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever, Rasmus O. Bak, Andreas Reinisch et al. · Nature · 2016 · 876 citations · Full text
Inference of CRISPR Edits from Sanger Trace Data
David S. Conant, Tim Hsiau, Nicholas A. Rossi et al. · The CRISPR Journal · 2022 · 839 citations
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
Iman Fares, Jalila Chagraoui, Yves Gareau et al. · Science · 2014 · 566 citations